A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma

NCT02512900 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: MEDI9929, 140 mg

Sponsor

MedImmune LLC

Collaborators

[object Object]